Global Transthyretin Amyloidosis (ATTR) Market Research Report 2023

Report ID: 1994638 | Published Date: Jan 2025 | No. of Page: 81 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Transthyretin Amyloidosis (ATTR) Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Hereditary ATTR (HATTR)
        1.2.3 Wild-Type (WT) ATTR
    1.3 Market by Application
        1.3.1 Global Transthyretin Amyloidosis (ATTR) Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Hospitals
        1.3.3 Ambulatory Surgical Centers
        1.3.4 Diagnostic Centers
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered
2 Global Growth Trends
    2.1 Global Transthyretin Amyloidosis (ATTR) Market Perspective (2018-2029)
    2.2 Transthyretin Amyloidosis (ATTR) Growth Trends by Region
        2.2.1 Global Transthyretin Amyloidosis (ATTR) Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Transthyretin Amyloidosis (ATTR) Historic Market Size by Region (2018-2023)
        2.2.3 Transthyretin Amyloidosis (ATTR) Forecasted Market Size by Region (2024-2029)
    2.3 Transthyretin Amyloidosis (ATTR) Market Dynamics
        2.3.1 Transthyretin Amyloidosis (ATTR) Industry Trends
        2.3.2 Transthyretin Amyloidosis (ATTR) Market Drivers
        2.3.3 Transthyretin Amyloidosis (ATTR) Market Challenges
        2.3.4 Transthyretin Amyloidosis (ATTR) Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Transthyretin Amyloidosis (ATTR) Players by Revenue
        3.1.1 Global Top Transthyretin Amyloidosis (ATTR) Players by Revenue (2018-2023)
        3.1.2 Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Players (2018-2023)
    3.2 Global Transthyretin Amyloidosis (ATTR) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Transthyretin Amyloidosis (ATTR) Revenue
    3.4 Global Transthyretin Amyloidosis (ATTR) Market Concentration Ratio
        3.4.1 Global Transthyretin Amyloidosis (ATTR) Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Transthyretin Amyloidosis (ATTR) Revenue in 2022
    3.5 Transthyretin Amyloidosis (ATTR) Key Players Head office and Area Served
    3.6 Key Players Transthyretin Amyloidosis (ATTR) Product Solution and Service
    3.7 Date of Enter into Transthyretin Amyloidosis (ATTR) Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Transthyretin Amyloidosis (ATTR) Breakdown Data by Type
    4.1 Global Transthyretin Amyloidosis (ATTR) Historic Market Size by Type (2018-2023)
    4.2 Global Transthyretin Amyloidosis (ATTR) Forecasted Market Size by Type (2024-2029)
5 Transthyretin Amyloidosis (ATTR) Breakdown Data by Application
    5.1 Global Transthyretin Amyloidosis (ATTR) Historic Market Size by Application (2018-2023)
    5.2 Global Transthyretin Amyloidosis (ATTR) Forecasted Market Size by Application (2024-2029)
6 North America
    6.1 North America Transthyretin Amyloidosis (ATTR) Market Size (2018-2029)
    6.2 North America Transthyretin Amyloidosis (ATTR) Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Transthyretin Amyloidosis (ATTR) Market Size by Country (2018-2023)
    6.4 North America Transthyretin Amyloidosis (ATTR) Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada
7 Europe
    7.1 Europe Transthyretin Amyloidosis (ATTR) Market Size (2018-2029)
    7.2 Europe Transthyretin Amyloidosis (ATTR) Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Transthyretin Amyloidosis (ATTR) Market Size by Country (2018-2023)
    7.4 Europe Transthyretin Amyloidosis (ATTR) Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Transthyretin Amyloidosis (ATTR) Market Size (2018-2029)
    8.2 Asia-Pacific Transthyretin Amyloidosis (ATTR) Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Transthyretin Amyloidosis (ATTR) Market Size by Region (2018-2023)
    8.4 Asia-Pacific Transthyretin Amyloidosis (ATTR) Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia
9 Latin America
    9.1 Latin America Transthyretin Amyloidosis (ATTR) Market Size (2018-2029)
    9.2 Latin America Transthyretin Amyloidosis (ATTR) Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Transthyretin Amyloidosis (ATTR) Market Size by Country (2018-2023)
    9.4 Latin America Transthyretin Amyloidosis (ATTR) Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Transthyretin Amyloidosis (ATTR) Market Size (2018-2029)
    10.2 Middle East & Africa Transthyretin Amyloidosis (ATTR) Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Transthyretin Amyloidosis (ATTR) Market Size by Country (2018-2023)
    10.4 Middle East & Africa Transthyretin Amyloidosis (ATTR) Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE
11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Detail
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Transthyretin Amyloidosis (ATTR) Introduction
        11.1.4 Pfizer Revenue in Transthyretin Amyloidosis (ATTR) Business (2018-2023)
        11.1.5 Pfizer Recent Development
    11.2 Alnylam Pharmaceuticals
        11.2.1 Alnylam Pharmaceuticals Company Detail
        11.2.2 Alnylam Pharmaceuticals Business Overview
        11.2.3 Alnylam Pharmaceuticals Transthyretin Amyloidosis (ATTR) Introduction
        11.2.4 Alnylam Pharmaceuticals Revenue in Transthyretin Amyloidosis (ATTR) Business (2018-2023)
        11.2.5 Alnylam Pharmaceuticals Recent Development
    11.3 Ionis Pharmaceuticals
        11.3.1 Ionis Pharmaceuticals Company Detail
        11.3.2 Ionis Pharmaceuticals Business Overview
        11.3.3 Ionis Pharmaceuticals Transthyretin Amyloidosis (ATTR) Introduction
        11.3.4 Ionis Pharmaceuticals Revenue in Transthyretin Amyloidosis (ATTR) Business (2018-2023)
        11.3.5 Ionis Pharmaceuticals Recent Development
    11.4 Corino Therapeutics
        11.4.1 Corino Therapeutics Company Detail
        11.4.2 Corino Therapeutics Business Overview
        11.4.3 Corino Therapeutics Transthyretin Amyloidosis (ATTR) Introduction
        11.4.4 Corino Therapeutics Revenue in Transthyretin Amyloidosis (ATTR) Business (2018-2023)
        11.4.5 Corino Therapeutics Recent Development
    11.5 Proclara Bioscience
        11.5.1 Proclara Bioscience Company Detail
        11.5.2 Proclara Bioscience Business Overview
        11.5.3 Proclara Bioscience Transthyretin Amyloidosis (ATTR) Introduction
        11.5.4 Proclara Bioscience Revenue in Transthyretin Amyloidosis (ATTR) Business (2018-2023)
        11.5.5 Proclara Bioscience Recent Development
    11.6 Arcturus Therapeutics
        11.6.1 Arcturus Therapeutics Company Detail
        11.6.2 Arcturus Therapeutics Business Overview
        11.6.3 Arcturus Therapeutics Transthyretin Amyloidosis (ATTR) Introduction
        11.6.4 Arcturus Therapeutics Revenue in Transthyretin Amyloidosis (ATTR) Business (2018-2023)
        11.6.5 Arcturus Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Transthyretin Amyloidosis (ATTR) Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Hereditary ATTR (HATTR)
    Table 3. Key Players of Wild-Type (WT) ATTR
    Table 4. Global Transthyretin Amyloidosis (ATTR) Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 5. Global Transthyretin Amyloidosis (ATTR) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 6. Global Transthyretin Amyloidosis (ATTR) Market Size by Region (2018-2023) & (US$ Million)
    Table 7. Global Transthyretin Amyloidosis (ATTR) Market Share by Region (2018-2023)
    Table 8. Global Transthyretin Amyloidosis (ATTR) Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 9. Global Transthyretin Amyloidosis (ATTR) Market Share by Region (2024-2029)
    Table 10. Transthyretin Amyloidosis (ATTR) Market Trends
    Table 11. Transthyretin Amyloidosis (ATTR) Market Drivers
    Table 12. Transthyretin Amyloidosis (ATTR) Market Challenges
    Table 13. Transthyretin Amyloidosis (ATTR) Market Restraints
    Table 14. Global Transthyretin Amyloidosis (ATTR) Revenue by Players (2018-2023) & (US$ Million)
    Table 15. Global Transthyretin Amyloidosis (ATTR) Market Share by Players (2018-2023)
    Table 16. Global Top Transthyretin Amyloidosis (ATTR) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transthyretin Amyloidosis (ATTR) as of 2022)
    Table 17. Ranking of Global Top Transthyretin Amyloidosis (ATTR) Companies by Revenue (US$ Million) in 2022
    Table 18. Global 5 Largest Players Market Share by Transthyretin Amyloidosis (ATTR) Revenue (CR5 and HHI) & (2018-2023)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Transthyretin Amyloidosis (ATTR) Product Solution and Service
    Table 21. Date of Enter into Transthyretin Amyloidosis (ATTR) Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Transthyretin Amyloidosis (ATTR) Market Size by Type (2018-2023) & (US$ Million)
    Table 24. Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Type (2018-2023)
    Table 25. Global Transthyretin Amyloidosis (ATTR) Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 26. Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Type (2024-2029)
    Table 27. Global Transthyretin Amyloidosis (ATTR) Market Size by Application (2018-2023) & (US$ Million)
    Table 28. Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Application (2018-2023)
    Table 29. Global Transthyretin Amyloidosis (ATTR) Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 30. Global Transthyretin Amyloidosis (ATTR) Revenue Market Share by Application (2024-2029)
    Table 31. North America Transthyretin Amyloidosis (ATTR) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 32. North America Transthyretin Amyloidosis (ATTR) Market Size by Country (2018-2023) & (US$ Million)
    Table 33. North America Transthyretin Amyloidosis (ATTR) Market Size by Country (2024-2029) & (US$ Million)
    Table 34. Europe Transthyretin Amyloidosis (ATTR) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 35. Europe Transthyretin Amyloidosis (ATTR) Market Size by Country (2018-2023) & (US$ Million)
    Table 36. Europe Transthyretin Amyloidosis (ATTR) Market Size by Country (2024-2029) & (US$ Million)
    Table 37. Asia-Pacific Transthyretin Amyloidosis (ATTR) Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 38. Asia-Pacific Transthyretin Amyloidosis (ATTR) Market Size by Region (2018-2023) & (US$ Million)
    Table 39. Asia-Pacific Transthyretin Amyloidosis (ATTR) Market Size by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Transthyretin Amyloidosis (ATTR) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 41. Latin America Transthyretin Amyloidosis (ATTR) Market Size by Country (2018-2023) & (US$ Million)
    Table 42. Latin America Transthyretin Amyloidosis (ATTR) Market Size by Country (2024-2029) & (US$ Million)
    Table 43. Middle East & Africa Transthyretin Amyloidosis (ATTR) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. Middle East & Africa Transthyretin Amyloidosis (ATTR) Market Size by Country (2018-2023) & (US$ Million)
    Table 45. Middle East & Africa Transthyretin Amyloidosis (ATTR) Market Size by Country (2024-2029) & (US$ Million)
    Table 46. Pfizer Company Detail
    Table 47. Pfizer Business Overview
    Table 48. Pfizer Transthyretin Amyloidosis (ATTR) Product
    Table 49. Pfizer Revenue in Transthyretin Amyloidosis (ATTR) Business (2018-2023) & (US$ Million)
    Table 50. Pfizer Recent Development
    Table 51. Alnylam Pharmaceuticals Company Detail
    Table 52. Alnylam Pharmaceuticals Business Overview
    Table 53. Alnylam Pharmaceuticals Transthyretin Amyloidosis (ATTR) Product
    Table 54. Alnylam Pharmaceuticals Revenue in Transthyretin Amyloidosis (ATTR) Business (2018-2023) & (US$ Million)
    Table 55. Alnylam Pharmaceuticals Recent Development
    Table 56. Ionis Pharmaceuticals Company Detail
    Table 57. Ionis Pharmaceuticals Business Overview
    Table 58. Ionis Pharmaceuticals Transthyretin Amyloidosis (ATTR) Product
    Table 59. Ionis Pharmaceuticals Revenue in Transthyretin Amyloidosis (ATTR) Business (2018-2023) & (US$ Million)
    Table 60. Ionis Pharmaceuticals Recent Development
    Table 61. Corino Therapeutics Company Detail
    Table 62. Corino Therapeutics Business Overview
    Table 63. Corino Therapeutics Transthyretin Amyloidosis (ATTR) Product
    Table 64. Corino Therapeutics Revenue in Transthyretin Amyloidosis (ATTR) Business (2018-2023) & (US$ Million)
    Table 65. Corino Therapeutics Recent Development
    Table 66. Proclara Bioscience Company Detail
    Table 67. Proclara Bioscience Business Overview
    Table 68. Proclara Bioscience Transthyretin Amyloidosis (ATTR) Product
    Table 69. Proclara Bioscience Revenue in Transthyretin Amyloidosis (ATTR) Business (2018-2023) & (US$ Million)
    Table 70. Proclara Bioscience Recent Development
    Table 71. Arcturus Therapeutics Company Detail
    Table 72. Arcturus Therapeutics Business Overview
    Table 73. Arcturus Therapeutics Transthyretin Amyloidosis (ATTR) Product
    Table 74. Arcturus Therapeutics Revenue in Transthyretin Amyloidosis (ATTR) Business (2018-2023) & (US$ Million)
    Table 75. Arcturus Therapeutics Recent Development
    Table 76. Research Programs/Design for This Report
    Table 77. Key Data Information from Secondary Sources
    Table 78. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Transthyretin Amyloidosis (ATTR) Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Transthyretin Amyloidosis (ATTR) Market Share by Type: 2022 VS 2029
    Figure 3. Hereditary ATTR (HATTR) Features
    Figure 4. Wild-Type (WT) ATTR Features
    Figure 5. Global Transthyretin Amyloidosis (ATTR) Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 6. Global Transthyretin Amyloidosis (ATTR) Market Share by Application: 2022 VS 2029
    Figure 7. Hospitals Case Studies
    Figure 8. Ambulatory Surgical Centers Case Studies
    Figure 9. Diagnostic Centers Case Studies
    Figure 10. Transthyretin Amyloidosis (ATTR) Report Years Considered
    Figure 11. Global Transthyretin Amyloidosis (ATTR) Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 12. Global Transthyretin Amyloidosis (ATTR) Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 13. Global Transthyretin Amyloidosis (ATTR) Market Share by Region: 2022 VS 2029
    Figure 14. Global Transthyretin Amyloidosis (ATTR) Market Share by Players in 2022
    Figure 15. Global Top Transthyretin Amyloidosis (ATTR) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transthyretin Amyloidosis (ATTR) as of 2022)
    Figure 16. The Top 10 and 5 Players Market Share by Transthyretin Amyloidosis (ATTR) Revenue in 2022
    Figure 17. North America Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 18. North America Transthyretin Amyloidosis (ATTR) Market Share by Country (2018-2029)
    Figure 19. United States Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 20. Canada Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. Europe Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. Europe Transthyretin Amyloidosis (ATTR) Market Share by Country (2018-2029)
    Figure 23. Germany Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. France Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. U.K. Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. Italy Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. Russia Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Nordic Countries Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Asia-Pacific Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Asia-Pacific Transthyretin Amyloidosis (ATTR) Market Share by Region (2018-2029)
    Figure 31. China Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Japan Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. South Korea Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Southeast Asia Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. India Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Australia Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Latin America Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Latin America Transthyretin Amyloidosis (ATTR) Market Share by Country (2018-2029)
    Figure 39. Mexico Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Brazil Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Middle East & Africa Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Middle East & Africa Transthyretin Amyloidosis (ATTR) Market Share by Country (2018-2029)
    Figure 43. Turkey Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Saudi Arabia Transthyretin Amyloidosis (ATTR) Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Pfizer Revenue Growth Rate in Transthyretin Amyloidosis (ATTR) Business (2018-2023)
    Figure 46. Alnylam Pharmaceuticals Revenue Growth Rate in Transthyretin Amyloidosis (ATTR) Business (2018-2023)
    Figure 47. Ionis Pharmaceuticals Revenue Growth Rate in Transthyretin Amyloidosis (ATTR) Business (2018-2023)
    Figure 48. Corino Therapeutics Revenue Growth Rate in Transthyretin Amyloidosis (ATTR) Business (2018-2023)
    Figure 49. Proclara Bioscience Revenue Growth Rate in Transthyretin Amyloidosis (ATTR) Business (2018-2023)
    Figure 50. Arcturus Therapeutics Revenue Growth Rate in Transthyretin Amyloidosis (ATTR) Business (2018-2023)
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation
    Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Alnylam Pharmaceuticals
Ionis Pharmaceuticals
Corino Therapeutics
Proclara Bioscience
Arcturus Therapeutics
Frequently Asked Questions
Transthyretin Amyloidosis (ATTR) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Transthyretin Amyloidosis (ATTR) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Transthyretin Amyloidosis (ATTR) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Baked Goods

This report aims to provide a comprehensive presentation of the global market for Baked Goods, wi ... Read More